OOIR: Observatory of International Research

Papers

(The median citation count of Schizophrenia Bulletin is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Consent for Research Involving Spanish- and English-Speaking Latinx Adults With Schizophrenia	113
Neural Correlates of Formal Thought Disorder Dimensions in Psychosis	79
Spontaneous Brain Activity Alterations in First-Episode Psychosis: A Meta-analysis of Functional Magnetic Resonance Imaging Studies	76
A Network Approach to Trauma, Dissociative Symptoms, and Psychosis Symptoms in Schizophrenia Spectrum Disorders	70
Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis	55
Letter to the Editor Regarding Concept of Race	51
Medical and Psychiatric Care Preceding the First Psychotic Disorder Diagnosis	50
Review of Major Social Determinants of Health in Schizophrenia-Spectrum Psychotic Disorders: III. Biology	43
An Evil Cradling: First-Person Account of Psychosis During Pregnancy	41
Awakening from Schizophrenia	36
The Direct and Long-Term Effects of Raloxifene as Adjunctive Treatment for Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Clinical Trial	36
On How to Create Nice Voices and How to Overcome Stigma	36
Blinders for Coping With Schizophrenia	34
Correction to: Understanding My Personal Schizophrenia	33
Correction to: Addressing the Evidence to Practice Gap: What to Expect From International Antipsychotic Dose Reduction Studies in the Tapering Anti-Psychotics and Evaluating Recovery Consortium	32
What Is Triggering My Stress?	32
Cumulative Environmental Risk in Early Life: Associations With Schizotypy in Childhood	30
Cross-Disorder Analysis of Shared Genetic Components Between Cortical Structures and Major Psychiatric Disorders	29
Lived Experience Research: A Guide to the Barriers and Facilitators From a Service User’s Perspective	29
Placebo Response in Trials of Negative Symptoms in Schizophrenia: A Critical Reassessment of the Evidence	29
Visuospatial Learning Selectively Enhanced by Personalized Transcranial Magnetic Stimulation over Parieto-Hippocampal Network among Patients at Clinical High-Risk for Psychosis	28
Longitudinal Investigation of Auditory Dynamic Range Deficits in Early Psychosis and its Relationship to Negative Symptoms	28
Hierarchical Symptom Components in Early Psychosis	28
Psychometric Properties and Diagnostic Associations of the Short-Form Community Assessment of Psychic Experiences in a Population-Based Sample of 29 021 Adult Men	27
Language and Psychosis: Tightening the Association	27

Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine: Randomized, Double-Blind Trial in Patients With Schizophrenia	27
Neurostructural, Neurofunctional, and Clinical Features of Chronic, Untreated Schizophrenia: A Narrative Review	25
Thinking About the Future of Cognitive Remediation Therapy Revisited: What Is Left to Solve Before Patients Have Access?	25
When Atypical Antipsychotics Were New	25
Spatiotemporal Alterations in Working Memory-Related Beta Band Neuromagnetic Activity of Patients With Schizophrenia On and Off Antipsychotic Medication: Investigation With MEG	25
Increased Belief Instability in Psychotic Disorders Predicts Treatment Response to Metacognitive Training	24
Physical Activity, Sleep, and Risk of Late-Onset Severe Mental Illness: A Prospective Cohort Study From UK Biobank	24
Early Schizotypy and Risk: The Need for Integrating Developmental Dynamics	24
The Difficulties of Grandiose Delusions: Harms, Challenges, and Implications for Treatment Engagement	24
Range-Adaptive Value Representation in Different Stages of Schizophrenia: A Proof of Concept Study	24
Correction to: Schizophrenia Polygenic Risk and Experiences of Childhood Adversity: A Systematic Review and Meta-analysis	23
Systematic Review and Meta-analysis: Rates of Violence During First-Episode Psychosis (FEP)	22
Cognitive Control System Gates Insula Processing of Affective Stimuli in Early Psychosis	22
Pleiotropic CACNA1C Variants and Neuronal Function in Psychosis	22
Systematic Review and Meta-analysis of Exercise Interventions for Psychotic Disorders: The Impact of Exercise Intensity, Mindfulness Components, and Other Moderators on Symptoms, Functioning, and Card	22
Evidence From Imaging Resilience Genetics for a Protective Mechanism Against Schizophrenia in the Ventral Visual Pathway	22
The Jury Is Still out on Placental Genes and Obstetric Complications	22
Correction to: The Difficulties of Grandiose Delusions: Harms, Challenges, and Implications for Treatment Engagement	22
Primary Negative Symptoms: Refining the Research Target	21
Clinical Consequences of Motor Behavior as Transdiagnostic Phenomenon	21
Introduction to “The Beginnings of Systematic Studies of the Genetics of Schizophrenia: 1916–1933”	21
Associating Multimodal Neuroimaging Abnormalities With the Transcriptome and Neurotransmitter Signatures in Schizophrenia	20
Identify Potential Causal Relationships Between Cortical Thickness, Mismatch Negativity, Neurocognition, and Psychosocial Functioning in Drug-Naïve First-Episode Psychosis Patients	20
False Responses From Artificial Intelligence Models Are Not Hallucinations	20
Clinical Assessment Interview for Negative Symptoms (CAINS): A Systematic Review of Measurement Properties	20
Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation—Is It Feasible to Develop Evidence-Based Guidelines?	20
Neural Basis of Speech-Gesture Mismatch Detection in Schizophrenia Spectrum Disorders	20
EEG-based Signatures of Schizophrenia, Depression, and Aberrant Aging: A Supervised Machine Learning Investigation	20
Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials	19
Methodological Characteristics and Feasibility of Ecological Momentary Assessment Studies in Psychosis: a Systematic Review and Meta-Analysis	19
Antipsychotic Medication and Risk of Metabolic Disorders in People With Schizophrenia: A Longitudinal Study Using the UK Clinical Practice Research Datalink	19
Maternal Schizophrenia and the Risk of a Childhood Chronic Condition	19
Effects of Exercise on Structural and Functional Brain Patterns in Schizophrenia—Data From a Multicenter Randomized-Controlled Study	19
Effects of a Novel, Transdiagnostic Ecological Momentary Intervention for Prevention, and Early Intervention of Severe Mental Disorder in Youth (EMIcompass): Findings From an Exploratory Randomized Co	18
Psychotic Disorders in Adolescence and Later Long-term Exclusion From Education and Employment	18
Amphetamine-Induced Dopamine Release Predicts 1-Year Outcome in First-Episode Psychosis: A Naturalistic Observation	18
Comparison of Acute Followed by Maintenance ECT vs Clozapine on Psychopathology and Regional Cerebral Blood Flow in Treatment-Resistant Schizophrenia: A Randomized Controlled Trial	18
Autistic Symptoms and Social Functioning in Psychosis: A Network Approach	18
The Role of Fatty Acid Amide Hydrolase, a Key Regulatory Endocannabinoid Enzyme, in Domain-Specific Cognitive Performance in Psychosis	18
Timely N-Acetyl-Cysteine and Environmental Enrichment Rescue Oxidative Stress-Induced Parvalbumin Interneuron Impairments via MMP9/RAGE Pathway: A Translational Approach for Early Intervention in Psyc	18
Depression and Psychosis Risk Shared Vulnerability for Motor Signs Across Development, Symptom Dimensions, and Familial Risk	18
Lived Experiences of Psychosis: Understanding the Gap Between Perception and Reality	18
A Transdiagnostic Study of Effort-Cost Decision-Making in Psychotic and Mood Disorders	18
Clinical Recovery Among Individuals With a First-Episode Schizophrenia an Updated Systematic Review and Meta-Analysis	17
A Deeper Dive Into the Relation Between Psychotic-like Experiences and Suicidal Ideation and Behaviors in Children Across the United States	17
Intact Serial Dependence in Schizophrenia: Evidence from an Orientation Adjustment Task	17
Effects of Substance Use and Antisocial Personality on Neuroimaging-Based Machine Learning Prediction of Schizophrenia	17
Corollary Discharge Dysfunction as a Possible Substrate of Anomalous Self-experiences in Schizophrenia	16
Shared Genetic Architecture Among Gastrointestinal Diseases, Schizophrenia, and Brain Subcortical Volumes	16
Measuring Cognitive Impairments Associated With Schizophrenia in Clinical Practice: Overview of Current Challenges and Future Opportunities	16

Correction to: Traumatic Brain Injury and Risk of Schizophrenia and Other Non-mood Psychotic Disorders: Findings From a Large Inpatient Database in the United States	16
Motor Behavior is Relevant for Understanding Mechanism, Bolstering Prediction, And Improving Treatment: A Transdiagnostic Perspective	16
Service User Representation in Qualitative Research on Cognitive Health and Related Interventions for Psychosis: A Scoping Review	16
Neuroretinal Alterations in Schizophrenia and Bipolar Disorder: An Updated Meta-analysis	16
Personalized Cognitive Health in Psychiatry: Current State and the Promise of Computational Methods	16
Correction to: Belief Updating, Childhood Maltreatment, and Paranoia in Schizophrenia-Spectrum Disorders	15
Improving the Applicability of AI for Psychiatric Applications through Human-in-the-loop Methodologies	15
The Puzzle of Functional Recovery in Schizophrenia-Spectrum Disorders—Replicating a Network Analysis Study	15
There Is Life After the UK Clozapine Central Non-Rechallenge Database	15
Impact of Early-Life Factors on Risk for Schizophrenia and Bipolar Disorder	15
Deep Learning-based Brain Age Prediction in Patients With Schizophrenia Spectrum Disorders	15
Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia	15
Functional Dysconnectivity in Ventral Striatocortical Systems in 22q11.2 Deletion Syndrome	14
Disentangling the Relationships Between the Clinical Symptoms of Schizophrenia Spectrum Disorders and Theory of Mind: A Meta-analysis	14
Measurement of Adverse Events in Studies of Digital Health Interventions for Psychosis: Guidance and Recommendations Based on a Literature Search and Framework Analysis of Standard Operating Procedure	14
Do Cognitive Subtypes Exist in People at Clinical High Risk for Psychosis? Results From the EU-GEI Study	14
Brain-Derived Neurotrophic Factor Val66Met Genotype Modulates Latent Inhibition: Relevance for Schizophrenia	14
Comparison of Negative Symptom Network Structures Between Patients With Early and Chronic Schizophrenia: A Network and Exploratory Graph Analysis	14
The Role of Religion and Ethnic Factors in My Recovery From 10 Years of Schizophrenia and Severe Depression	14
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study	14
Symptom Structure in Schizophrenia: Implications of Latent Variable Modeling vs Network Analysis	14
Phenomenological and Cognitive Features Associated With Auditory Hallucinations in Clinical and Nonclinical Voice Hearers	13
Network Localization of State and Trait of Auditory Verbal Hallucinations in Schizophrenia	13
White Matter Metabolite Relaxation and Diffusion Abnormalities in First-Episode Psychosis: A Longitudinal Study	13
Controllability of Functional Brain Networks and Its Clinical Significance in First-Episode Schizophrenia	13
Long-Term Real-World Effectiveness of Pharmacotherapies for Schizoaffective Disorder	13
Durable Cognitive Gains and Symptom Improvement Are Observed in Individuals With Recent-Onset Schizophrenia 6 Months After a Randomized Trial of Auditory Training Completed Remotely	13
Social Motivation in Schizophrenia: What’s Effort Got to Do With It?	13
Exploring the Relationship Between Movement Disorders and Physical Activity in Patients With Schizophrenia: An Actigraphy Study	13
Is Clozapine-induced Weight Gain Dose-dependent? Results From a Prospective Cohort Study	13
Examining Psychosis Risk in Sexual Minority Youth: Increased Exposure to and Differential Impact of the Social Envirome in Early Adolescence	13
Longitudinal MicroRNA Signature of Conversion to Psychosis	13
Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to Brain	12
Early Intervention Services for Schizophrenia: Looking Back and Looking Ahead	12
Macroscale Thalamic Functional Organization Disturbances and Underlying Core Cytoarchitecture in Early-Onset Schizophrenia	12
Focused Ultrasound Stimulates the Prefrontal Cortex and Prevents MK-801-Induced Psychiatric Symptoms of Schizophrenia in Rats	12
Dynamic and Static Cognitive Deficits in Schizophrenia and Bipolar Disorder After the First Episode	12
Cognitive Behavioral Therapy for Prodromal Stage of Psychosis—Outcomes for Transition, Functioning, Distress, and Quality of Life: A Systematic Review and Meta-analysis	12
Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders	12
Safety of rTMS for Schizophrenia: A Systematic Review and Meta-analysis	12
Neuropsychological Performance Among Individuals at Clinical High-Risk for Psychosis vs Putatively Low-Risk Peers With Other Psychopathology: A Systematic Review and Meta-Analysis	12
Natural Language Processing Markers for Psychosis and Other Psychiatric Disorders: Emerging Themes and Research Agenda From a Cross-Linguistic Workshop	12
Personalized Estimates of Brain Structural Variability in Individuals With Early Psychosis	12
Quantifying Retinal Microvascular Morphology in Schizophrenia Using Swept-Source Optical Coherence Tomography Angiography	11
Defining Urbanicity in the Context of Psychosis Research: A Qualitative Systematic Literature Review	11
Hallucination Proneness Alters Sensory Feedback Processing in Self-voice Production	11
Evidence of Neurovascular Water Exchange and Endothelial Vascular Dysfunction in Schizophrenia: An Exploratory Study	11
Differential Trajectories of Delusional Content and Severity Over 2 Years of Early Intervention for Psychosis: Comparison Between Chennai, India, and Montréal, Canada	11
Derivation and Molecular Characterization of a Morphological Subpopulation of Human iPSC Astrocytes Reveal a Potential Role in Schizophrenia and Clozapine Response	11
A Nationwide Cohort Study of Nonrandom Mating in Schizophrenia and Bipolar Disorder	11
What do the Voices Say?	11
Disturbed Oligodendroglial Maturation Causes Cognitive Dysfunction in Schizophrenia: A New Hypothesis	11
A Bayesian Network Approach to Social and Nonsocial Cognition in Schizophrenia: Are Some Domains More Fundamental than Others?	11
Evaluating the Exposome Score for Schizophrenia in a Transdiagnostic Psychosis Cohort: Associations With Psychosis Risk, Symptom Severity, and Personality Traits	11
Epigenetic Element-Based Transcriptome-Wide Association Study Identifies Novel Genes for Bipolar Disorder	11
Advances in Hallucination Research	11
Chatbots and Stigma in Schizophrenia: The Need for Transparency	11
Cognitive Mechanisms of Aberrant Self-Referential Social Perception in Psychosis and Bipolar Disorder: Insights From Computational Modeling	11
My Journey of Awakening From Schizophrenia and Rediscovering Humanity	11
Response to Commentaries	11
Retraction to: M111. Quantitative Assessment of Mania and Psychosis During Hospitalization Using Automated Analysis of Face, Voice, and Language	10
Early Childhood Neurocognition in Relation to Middle Childhood Psychotic Experiences in Children at Familial High Risk of Schizophrenia or Bipolar Disorder and Population-Based Controls: The Danish Hi	10
Familial Risk for Schizophrenia vs Bipolar Disorder and Task-Based Neural Activation: A functional Magnetic Resonance Imaging Meta-Analysis	10
Correction to: Heightened COVID-19 Mortality in People With Severe Mental Illness Persists After Vaccination: A Cohort Study of Greater Manchester Residents	10
Measures of Social and Occupational Function in Early Psychosis: A Systematic Review and Meta-analysis	10
Approaches to Studying and Improving Social Motivation in Schizophrenia	10
Effect of Intranasal Oxytocin on Resting-state Effective Connectivity in Schizophrenia	10
Childhood Trauma As a Mediator of the Association Between Autistic Traits and Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and Children Cohort	10
Sleep Problems, Suicidal Ideation, and Psychopathology in First-Episode Psychosis	10
The Thought From the Machine: Neural Basis of Thoughts With a Coherent and Diminished Sense of Authorship	10
The Triad of Childhood-Onset Schizophrenia, Autism Spectrum Disorder, and Catatonia: A Case Report	10
Effects on Multimodal Connectivity Patterns in Female Schizophrenia During 8 Weeks of Antipsychotic Treatment	10
Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation	10
Mental Illness and Mental Health in Nursing Homes	10
Correction to: Spatial and Temporal Abnormalities of Spontaneous Fixational Saccades and Their Correlates With Positive and Cognitive Symptoms in Schizophrenia	10
Obstructive Sleep Apnea Is Treatable With Continuous Positive Airway Pressure in People With Schizophrenia and Other Psychotic Disorders	9
A Sex-Dependent Association Between Doxycycline Use and Development of Schizophrenia	9
The Scanner as the Stimulus: Deficient Gamma-BOLD Coupling in Schizophrenia at Rest	9
Will Generative Artificial Intelligence Chatbots Generate Delusions in Individuals Prone to Psychosis?	9
“It’s Tough to Be a Black Man with Schizophrenia”: Randomized Controlled Trial of a Brief Video Intervention to Reduce Public Stigma	9

Is Collaborative Open Science Possible With Speech Data in Psychiatric Disorders?	9
Lack of Support for the Genes by Early Environment Interaction Hypothesis in the Pathogenesis of Schizophrenia	9
Neurological Soft Signs Are Associated With Altered White Matter in Patients With Schizophrenia	9
Improving our Understanding of Early Psychosis: Learning from the Optimise Trial	9
Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case–Control Study	9
International Experience of Implementing Cognitive Remediation for People With Psychotic Disorders	9
Linking Polygenic Risk of Schizophrenia to Variation in Magnetic Resonance Imaging Brain Measures: A Comprehensive Systematic Review	9
Childhood Adversity Determines the Syndemic Effects of Violence, Substance Misuse, and Sexual Behavior on Psychotic Spectrum Disorder Among Men	9
Schizophrenia and the Self	9
Jumping to Conclusions and Its Associations With Psychotic Experiences in Preadolescent Children at Familial High Risk of Schizophrenia or Bipolar Disorder-The Danish High Risk and Resilience Study, V	9
Poems	9
A Soldier Comes Home and a War With Schizophrenia Begins	9
The Humor in Schizophrenia	9
Sexual and Reproductive Health in Adolescents and Young Adults With Psychotic Disorders: A Scoping Review	9
Rare Copy Number Variation in Schizophrenia and Implications for Treatment	9
Familiality of the Intelligence Quotient in First Episode Psychosis: Is the Degree of Family Resemblance Associated With Different Profiles?	9
Heterogeneous Brain Abnormalities in Schizophrenia Converge on a Common Network Associated With Symptom Remission	9
Predicting Long-Term Outcomes in First-Admission Psychosis: Does the Hierarchical Taxonomy of Psychopathology Aid DSM in Prognostication?	9
Hyperactivity is a Core Endophenotype of Elevated Neuregulin-1 Signaling in Embryonic Glutamatergic Networks	9
Early NMDA Receptor Ablation in Interneurons Causes an Activity-Dependent E/I Imbalance in vivo in Prefrontal Cortex Pyramidal Neurons of a Mouse Model Useful for the Study of Schizophrenia	8
Relapse Following Electroconvulsive Therapy for Schizophrenia: A Systematic Review and Meta-analysis	8
Antipsychotic Medications: Enhancing Use to Improve Outcomes	8
Can the Predictive Processing Framework Explain the Persistence of Delusional Beliefs?	8
Immune-Inflammatory Response And Compensatory Immune-Regulatory Reflex Systems And White Matter Integrity in Schizophrenia	8
Unlocking the Therapeutic Potential of Exosomes Derived From Nasal Olfactory Mucosal Mesenchymal Stem Cells: Restoring Synaptic Plasticity, Neurogenesis, and Neuroinflammation in Schizophrenia	8
Network Analysis of Symptom Comorbidity in Schizophrenia: Relationship to Illness Course and Brain White Matter Microstructure	8
A Kind Gesture in the Psych Ward	8
A Developmental Perspective on Early and Current Motor Abnormalities and Psychotic-Like Symptoms	8
The Association Between Chronic Tobacco Smoking and Brain Alterations in Schizophrenia: A Systematic Review of Magnetic Resonance Imaging Studies	8
Understanding the Causal Pathway of Social Determinants of Psychosis: The Role of Social Functioning, Relevance of Animal Models, and Implications for Treatment	8
Plasma Levels of the Cytokines B Cell-Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Schizophrenia, Bipolar, and Major Depressive Disorder: A Cross Sectional, Multisite Study	8
Transcranial Magnetic Stimulation—A Patient’s First-Person Account on the Treatment of Schizophrenia’s Negative Symptoms (Avolition)	8
Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial	8
Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial	8
Racial and Ethnic Biases in Computational Approaches to Psychopathology	8
Hermann Hoffmann’s 1921 Monograph: “The Offspring of Endogenous Psychoses: Genealogical-Characterological Examinations”	8
Predictors of Mortality Following a Schizophrenia Spectrum Diagnosis: Evidence From the 20-Year Follow-up of the OPUS Randomized Controlled Trial	8
Associations Between Structural Covariance Network and Antipsychotic Treatment Response in Schizophrenia	8
Sleep Disturbance in Individuals at Clinical High Risk for Psychosis	8
Disease Progression Patterns of Brain Morphology in Schizophrenia: More Progressed Stages in Treatment Resistance	8
Dysconnectivity in Schizophrenia Revisited: Abnormal Temporal Organization of Dynamic Functional Connectivity in Patients With a First Episode of Psychosis	7
Speech Illusions in People at Clinical High Risk for Psychosis Linked to Clinical Outcome	7
Correction to: Evaluation of the Electroconvulsive Therapy’s Impact on Retinal Structures in First-Episode Psychosis Patients Using Optical Coherence Tomography	7
Language Analytics for Assessment of Mental Health Status and Functional Competency	7
Genetic Implication of Prenatal GABAergic and Cholinergic Neuron Development in Susceptibility to Schizophrenia	7
Longitudinal Network Analysis Reveals Interactive Change of Schizophrenia Symptoms During Acute Antipsychotic Treatment	7
Increased Sensitivity to Effort and Perception of Effort in People with Schizophrenia	7
Influences on the Genetic Relationship Between Cannabis Use and Schizophrenia: The Role of the Externalizing Spectrum	7
Structural Covariance of Cortical Gyrification at Illness Onset in Treatment Resistance: A Longitudinal Study of First-Episode Psychoses	7
Delusion and Reason	7
Emergence of Language Related to Self-experience and Agency in Autobiographical Narratives of Individuals With Schizophrenia	7
Bruno Schulz’s 1933 Monograph: On the Hereditary Etiology of Schizophrenia	7
Corrigendum to: A Network of Psychopathological, Cognitive, and Motor Symptoms in Schizophrenia Spectrum Disorders	7
Maternal Schizophrenia, Skin-to-Skin Contact, and Infant Feeding Initiation	7
Extracting Circadian and Sleep Parameters from Longitudinal Data in Schizophrenia for the Design of Pragmatic Light Interventions	7
Serum Metabolic Profile in Schizophrenia Patients With Antipsychotic-Induced Constipation and Its relationship With Gut Microbiome	7
Semantic Speech Networks Linked to Formal Thought Disorder in Early Psychosis	7
Long-Term Outcomes of First-Admission Psychosis: A Naturalistic 21-Year Follow-Up Study of Symptomatic, Functional and Personal Recovery and Their Baseline Predictors	7
Neural Signatures of Predictive Strategies Track Individuals Along the Autism-Schizophrenia Continuum	7
Multitrait Genetic Analysis Identifies Novel Pleiotropic Loci for Depression and Schizophrenia in East Asians	7
Imbalance Model of Heart Rate Variability and Pulse Wave Velocity in Psychotic and Nonpsychotic Disorders	7
Heightened COVID-19 Mortality in People With Severe Mental Illness Persists After Vaccination: A Cohort Study of Greater Manchester Residents	7
Cognitive Behavioral Psychotherapy as an Add-on in Comprehensive Outpatient Care of Non-affective Psychoses: A Multicenter Randomized-Controlled Effectiveness Trial in a Naturalistic Setting	7
Oculomics in Schizophrenia Research	7
Impaired Membrane Lipid Homeostasis in Schizophrenia	7
Voice Patterns as Markers of Schizophrenia: Building a Cumulative Generalizable Approach Via a Cross-Linguistic and Meta-analysis Based Investigation	7
Antipsychotics Effects on Network-Level Reconfiguration of Cortical Morphometry in First-Episode Schizophrenia	7
Efficacy of User Self-Led and Human-Supported Digital Health Interventions for People With Schizophrenia: A Systematic Review and Meta-Analysis	7
Unraveling the Prefrontal Cortex-Basolateral Amygdala Pathway’s Role on Schizophrenia’s Cognitive Impairments: A Multimodal Study in Patients and Mouse Models	7
N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms	7
An Introduction to the Human Connectome Project for Early Psychosis	7
Genetic Liability for Schizophrenia and Childhood Psychopathology in the General Population	7
Subtyping Schizophrenia Patients Based on Patterns of Structural Brain Alterations	6
Clinician-Reported Negative Symptom Scales: A Systematic Review of Measurement Properties	6
A 10-Year Longitudinal Study of Brain Cortical Thickness in People with First-Episode Psychosis Using Normative Models	6
Fronto-Temporal Disconnection Within the Presence Hallucination Network in Psychotic Patients With Passivity Experiences	6
The Effects of Cognitive Remediation on Negative Symptoms in Schizophrenia-Spectrum Illness: A Meta-analytic Investigation of Efficacy	6
Making Sense of Recovery From First Psychosis With Antipsychotic Medication: A Qualitative Phenomenological Study	6
N-Methyl-d-Aspartate Receptor Antibody and Sensory Gating Deficits in Non-smoking, Minimal Antipsychotic Medication Exposure, and First-Episode Patients With Schizophrenia	6
Language Network Dysfunction and Formal Thought Disorder in Schizophrenia	6
Genetically Informed Study Highlights Income-Independent Effect of Schizophrenia Liability on Mental and Physical Health	6
Advances in MRI Research for First-Episode Schizophrenia: A Selective Review and NSFC-Funded Analysis	6
miR-936 is Increased in Schizophrenia and Inhibits Neural Development and AMPA Receptor-Mediated Synaptic Transmission	6
Antipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness: Replication of a Nationwide Nested Case–Control Database Study	6
Adverse Events Reporting in Digital Interventions Evaluations for Psychosis: A Systematic Literature Search and Individual Level Content Analysis of Adverse Event Reports	6
Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis	6
Dynamics of Sharing Lived Experience	6
Semantic and Acoustic Markers in Schizophrenia-Spectrum Disorders: A Combinatory Machine Learning Approach	6
Longitudinal Trajectories of Premorbid Social and Academic Adjustment in Youth at Clinical High Risk for Psychosis: Implications for Conversion	6
Treatment and Mortality Following Cancer Diagnosis Among People With Non-affective Psychotic Disorders in Ontario, Canada: A Retrospective Cohort Study	6
Language, Motor Ability and Related Deficits in Children at Familial Risk of Schizophrenia or Bipolar Disorder	6
Schizophrenia-Like Deficits and Impaired Glutamate/Gamma-aminobutyric acid Homeostasis in Zfp804a Conditional Knockout Mice	6
Update of the World Health Organization’s Mental Health Gap Action Programme Guideline for Psychoses (Including Schizophrenia)	6
Measuring Voluntary Control Over Hallucinations: The Yale Control Over Perceptual Experiences (COPE) Scales	5
Neurocognitive Subgroups in Children at Familial High-risk of Schizophrenia or Bipolar disorder: Subgroup Membership Stability or Change From Age 7 to 11—The Danish High Risk and Resilience Study	5